RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL

Clinical trial NCT06674096 · RECRUITING

Trial details

NCT number: NCT06674096
Sponsor: Zhejiang Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Double-expressor Lymphoma

Start date: 2024-11-06
Primary completion: 2029-12-30
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.